Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Luiz Filipe Gonçalves de Oliveira"'
Autor:
Karen dos Santos Charret, Luiz Filipe Gonçalves de Oliveira, Carlos Roberto Alves, Raquel Aparecida Souza, Luzia Monteiro de Castro Côrtes, Laura Barral-Veloso, Matheus Pereira de Sá-Silva, Franklin Souza da Silva
Publikováno v:
Experimental Parasitology. 184:67-81
Serine proteases have significant functions over a broad range of relevant biological processes to the Leishmania spp lifecycle. Data gathered here present an update on the Leishmania spp serine proteases and the status of these enzymes as part of th
Autor:
Bernardo Acácio Santini Pereira, Luiz Filipe Gonçalves de Oliveira, Carlos Roberto Alves, Leandro Rocha, Benjamin Gilbert, Arthur L. Corrêa
Publikováno v:
Phytochemistry Reviews. 16:219-233
The interest in phytopharmaceutical products and herbal medicines has been a trend in recent years and this approach may be useful as basis for developing new treatment against leishmaniasis. In this review, we discuss the perspectives of leishmanias
Autor:
Luiz Filipe Gonçalves de Oliveira, Carlos Roberto Alves, Franklin Souza-Silva, Vitor F. Ferreira, Léa Cysne-Finkelstein, Francisco Odêncio de Oliveira Junior, R.T. Pinho, Suzana Corte Real, Luzia Monteiro de Castro Côrtes, Saulo Cabral Bourguignon, Mirian Claudia de Souza Pereira
Publikováno v:
Molecules; Volume 23; Issue 4; Pages: 864
Molecules, Vol 23, Iss 4, p 864 (2018)
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 23, Iss 4, p 864 (2018)
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Epoxymethoxylawsone is a naphthoquinone derivative promising as drug candidate for the treatment of leishmaniases. In the present work the effectiveness of epoxymethoxylawsone, and meglumine antimoniate on Leishmania (Leishmania) amazonensis parasite
Autor:
Franklin Souza-Silva, Carlos Roberto Alves, Vitor F. Ferreira, Léa Cysne-Finkelstein, Marciano Viana Paes, Kíssila Rabelo, Luiz Filipe Gonçalves de Oliveira, Adriana de Souza Azevedo, Saulo Cabral Bourguignon, Juliana Fernandes da Silva Amorim
Publikováno v:
BioMed Research International, Vol 2017 (2017)
BioMed Research International
BioMed Research International
Leishmaniasis remains a serious public health problem in developing countries without effective control, whether by vaccination or chemotherapy. Part of the failure of leishmaniasis control is due to the lack of new less toxic and more effective drug
Autor:
Carlos Roberto Alves, Mariana Silva-Almeida, Bernardo Acácio Santini Pereira, Franklin Souza-Silva, Raquel Santos-de-Souza, Michelle Lopes Ribeiro-Guimarães, Luiz Filipe Gonçalves de Oliveira
Publikováno v:
Current Drug Targets. 15:1121-1131
This review presents and discusses the current status and perspectives of leishmaniasis treatment, with a special focus on the use of proteinase inhibitors. The history of treatment development, the first- and second-choice modern drugs and the advan
Publikováno v:
Revista Fitos. 8:33-42
A leishmaniose é considerada uma das doenças mais negligenciadas. Os medicamentos de escolha para todas as formas de leishmaniose ainda são os antimoniais pentavalentes. A anfotericina B e pentamidina são relegadas à segunda linha pela toxicidad
Autor:
Carlos Augusto Ferreira de Andrade, Luiz Filipe Gonçalves de Oliveira, Maria de Fátima Moreira Martins, Sonia Regina Lambert Passos, Raquel de Vasconcellos Carvalhaes de Oliveira, Armando de Oliveira Schubach, Mauro Célio de Almeida Marzochi
Publikováno v:
Acta Tropica. 118(2):87-96
Pentavalent antimonials are first-line drugs for the treatment of the cutaneous form of American tegumentary leishmaniasis. Second-line drugs include amphotericin B and pentamidine. Although these drugs have been used for decades, there are no system
Autor:
R.T. Pinho, Ernesto Raul Caffarena, Paula F. Carneiro, Franklin Souza-Silva, Bernardo Acácio Santini Pereira, Luiz Filipe Gonçalves de Oliveira, Vitor F. Ferreira, Carlos Roberto Alves, Saulo Cabral Bourguignon, Luzia Monteiro de Castro Côrtes, Léa Cysne Finkelstein, Andrea Henriques-Pons
Leishmania ( Leishmania ) amazonensis is a protozoan that causes infections with a broad spectrum of clinical manifestations. The currently available chemotherapeutic treatments present many problems, such as several adverse side effects and the deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a8ec6b49e5c6edc15c642e6e22d010b
https://europepmc.org/articles/PMC4356828/
https://europepmc.org/articles/PMC4356828/